AJP - Lung Columbus Instruments
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Lung Cell Mol Physiol 297: L251-L262, 2009. First published May 22, 2009; doi:10.1152/ajplung.90565.2008
1040-0605/09 $8.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental Figures
Right arrow All Versions of this Article:
297/2/L251    most recent
90565.2008v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Google Scholar
Right arrow Articles by Testa, J. E.
Right arrow Articles by Schnitzer, J. E.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Testa, J. E.
Right arrow Articles by Schnitzer, J. E.

Immunotargeting and cloning of two CD34 variants exhibiting restricted expression in adult rat endothelia in vivo

Jacqueline E. Testa, Adrian Chrastina, Phil Oh, Yan Li, Halina Witkiewicz, Malgorzata Czarny, Tim Buss, and Jan E. Schnitzer

Proteogenomics Research Institute For Systems Medicine, Sidney Kimmel Cancer Center, San Diego, California

Submitted 17 November 2008 ; accepted in final form 13 May 2009

Mapping protein expression of endothelial cells (EC) in vivo is fundamental to understanding cellular function and may yield new tissue-selective targets. We have developed a monoclonal antibody, MAb J120, to a protein expressed primarily in rat lung and heart endothelium. The antigen was identified as CD34, a marker of hematopoietic stem cells and global marker of endothelial cells in human and mouse tissues. PCR-based cloning identified two CD34 variant proteins, full length and truncated, both of which are expressed on luminal endothelial cell plasma membranes (P) isolated from lung. Truncated CD34 predominated in heart P, and neither variant was detected in P from kidney or liver. CD34 in lung was readily accessible to 125I-J120 inoculated intravenously, and immunohistochemistry showed strong CD34 expression in lung EC. Few microvessels stained in heart and kidney, and no CD34 was detected in vessels of other organs or in lymphatics. We present herein the first complete sequence of a rat CD34 variant and show for the first time that the encoded truncated variant is endogenously expressed on EC in vivo. We also demonstrate that CD34 expression in rat EC, unlike mouse and human, is restricted in its distribution enabling quite specific lung targeting in vivo.

immunohistochemistry; immunofluorescence; PCR; SPECT imaging; biodistribution



Address for reprint requests and other correspondence: J. E. Testa and J. E. Schnitzer, Proteogenomics Research Institute For Systems Medicine, 11107 Roselle St., San Diego, CA 92121 (e-mail: jtesta{at}prism-sd.org and jschnitzer{at}prism-sd.org)







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2009 by the American Physiological Society.